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Case Report
Sinonasal Undifferentiated Carcinoma and Esthesioneuroblastoma
Recurring as Nonintestinal Adenocarcinoma
Stephen Y. Kang, MD; Jonathan B. McHugh, MD; Stephen E. Sullivan, MD;
Lawrence J. Marentette, MD; Erin L. McKean, MD
Numerous distinct neoplasms are encountered at the anterior cranial base. Management of these primary tumors and
their locoregional recurrences are dictated by the histopathologic diagnosis. We present two unusual cases of extra-axial
anterior cranial base malignancies with locoregional recurrence where the recurrent tumor encountered was of a distinct his-
topathologic type. While rare, this report highlights the possibility of encountering a distinct tumor type in the posttreatment
surveillance of patients with anterior cranial base malignancies.
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INTRODUCTION
The management of extra-axial malignancies
involving the anterior cranial base is largely predicated
on the histopathology of the tumor. Numerous distinct
neoplasms are encountered in this region, and accurate
histopathological diagnosis determines the appropriate
treatment plan for these patients. Similarly, the initial
management of locoregional recurrence of these tumors
is often guided by the known biology of the original
tumor. We present two cases of anterior cranial base
malignancies with suspected locoregional recurrence.
However, in both cases, the recurrent tumor encountered
was of a distinct histopathologic type.
CASE REPORT
Patient 1
A 39-year-old man presented with nasal obstruction
and recurrent epistaxis. Magnetic resonance imaging
(MRI) of the skull base showed a mass centered in the right
posterior ethmoid that extended into the superior nasal
cavity, penetrating the cribriform plate into the anterior
cranial fossa (Fig. 1). Endoscopic nasal biopsy of this lesion
revealed sinonasal undifferentiated carcinoma (SNUC).
The patient was subsequently referred to our institu-
tion where surgical extirpation was performed. The
anterior subcranial approach used at our institution for
open skull base procedures has been previously described.1
The pathologic diagnosis of the surgical specimen con-
firmed SNUC (Fig. 2). Postoperatively, the patient
underwent adjuvant cisplatin therapy and concurrent
radiation therapy to a total dose of 48 Gy.
One year after surgery, two intracranial lesions
were detected on surveillance imaging. These lesions
were dural-based and near the right pterion, suspicious
for subarachnoid dissemination of the SNUC. The
patient underwent radiosurgery, delivering 18 Gy to
both lesions. One year following radiosurgery, MRI
showed progression of an enhancing dural mass near
the right pterion (Fig. 3). There was no evidence of addi-
tional metastatic disease or recurrence at the primary
site. Neurosurgical extirpation of this enlarging mass
was performed. Final pathology of this lesion confirmed
high-grade nonintestinal adenocarcinoma (Fig. 4).
Patient 2
A 58-year-old man presented with an intranasal mass
and underwent endoscopic biopsy of the lesion, which
revealed esthesioneuroblastoma (Fig. 5). He underwent
endoscopic subtotal sinonasal debulking and adjuvant
radiation therapy to a total dose of 60 Gy to the primary
site. Eight years later, he developed recurrent epistaxis, and
a polypoid mass was identified in the right nasal cavity.
He was subsequently referred to our institution for
management of a suspected locally recurrent esthesion-
euroblastoma.
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Imaging showed an enhancing mass centered in the
left anterior and posterior ethmoid sinuses (Fig. 6). Endo-
scopic biopsy revealed intermediate-grade nonintestinal
adenocarcinoma. Surgical extirpation was performed via
an anterior subcranial approach. Pathologic review of the
surgical specimen confirmed intermediate-grade nonin-
testinal type adenocarcinoma; chromogranin staining and
pan-cytokeratin immunostaining suggest a change in
tumor phenotype (Fig. 7).
DISCUSSION
Malignancies of the extra-axial anterior skull base
represent a diverse group of histopathologic tumor
Fig. 2. Histopathologic features of high-grade SNUC in patient 1,
displaying sheets of malignant cells with round to oval vesicular
nuclei and frequent mitoses (A) and no evidence of squamous,
glandular, or neuroendocrine differentiation (B). Hematoxylin and
eosin (H&E) stain; original magnification 10 (A) and 20 (B).
Fig. 3. Coronal (A) and axial (B) post-contrast T1-weighted MRI
showing a persistent dural-based lesion in patient 1 one year fol-
lowing radiosurgery. Neurosurgical extirpation revealed nonintesti-
nal adenocarcinoma.
Fig. 1. Coronal (A) and sagittal (B) post-contrast T1-weighted MRI
showing a mass centered in the right posterior ethmoid penetrat-
ing the cribriform plate into the anterior cranial fossa.
Fig. 4. Histopathologic features of adenocarcinoma in patient 1,
displaying mucinous material with scattered areas of gland-form-
ing epithelium. H&E; original magnification 10 (A) and 20 (B).
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pathology. This group includes, but is not limited to:
squamous cell carcinoma, adenocarcinoma, adenoid
cystic carcinoma, melanoma, esthesioneuroblastoma,
SNUC, nasopharyngeal undifferentiated carcinoma, sar-
coma, and skin malignancies.2–4 The management of
anterior skull base malignancies is dependent on a num-
ber of important factors. Accurate tumor histopathology
is the cornerstone on which the treatment plan is
formed, and also an important prognostic factor for pre-
dicting the likelihood of treatment success and overall
survival in skull base malignancies.5,6 Likewise, the
management of recurrent disease depends on the known
biology of the primary tumor. This report describes
unexpected findings in two patients with anterior skull
base malignancies, presenting with suspected regional
recurrence in patient 1 and suspected local recurrence in
patient 2, where the recurrent tumor encountered was
of a distinct histopathologic type.
Sinonasal undifferentiated carcinoma was the origi-
nal pathologic diagnosis in case 1. During this patient’s
initial resection, there was evidence of dural invasion;
thus, the dural-based lesion that was found on postoper-
ative tumor surveillance MRI was attributed to
leptomeningeal spread of the SNUC. Review of the
SNUC and nonintestinal adenocarcinoma specimens by
a single pathologist (J.M.) confirmed both pathologic diag-
noses. A second primary adenocarcinoma with dural
metastasis is possible, although a second primary lesion
Fig. 5. Histopathologic features of esthesioneuroblastoma in patient 2, displaying nests of small round blue cells in the characteristic ‘‘salt
and pepper’’ appearance, surrounded by vascular stroma (A and B). H&E; original magnification 10 (A) and 20 (B). Chromogranin stain-
ing confirms a neuroendocrine tumor consistent with esthesioneuroblastoma (C) and pan-cytokeratin immunostaining, a marker for epithelial
differentiation, corresponds with rare areas of glandular differentiation, but the majority of the tumor is negative (D). Original magnification
10 (C) and 20 (D).
Fig. 6. Coronal (A) and axial (B) post-contrast T1-weighted MRI in
patient 2. Surgical extirpation revealed nonintestinal adenocarcinoma.
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has yet to be identified in this patient in over 13 years
of follow-up. Another possibility is the presence of a
hybrid tumor consisting of multiple pathologic features,
resulting in sampling error on the initial biopsy and sur-
gical specimen. The initial tumor may have exhibited
glandular pathologic features that were not identified
due to sampling error during specimen processing.
Finally, a rare genetic event resulting in transformation
of the tumor from SNUC to adenocarcinoma may have
occurred.
Esthesioneuroblastoma was the original pathologic
diagnosis in case 2. The patient presented with an intra-
nasal mass and a suspected local recurrence. Review of
the esthesioneuroblastoma and the nonintestinal adeno-
carcinoma specimens by a single pathologist (J.M.)
confirmed the pathologic diagnoses. Although pathologic
criteria for esthesioneuroblastoma were met with the
original specimen, rare areas of glandular differentiation
existed (Fig. 5). While esthesioneuroblastoma is in gen-
eral a radiosensitive tumor, it is possible that glandular
elements of the tumor were resistant to radiotherapy
and ultimately resulted in the recurrence of this tumor
as a nonintestinal adenocarcinoma.
CONCLUSION
Accurate tumor histopathology is imperative in the
management of anterior skull base malignancies. This
report describes two rare occurrences in which the
authors encountered an unexpected and distinct tumor
type when managing suspected locoregional recurrence
of anterior skull base malignancies. The initial manage-
ment of locoregional recurrence is often based on the
known biology of the primary tumor. Although rare,
the possibility of encountering a distinct tumor type in
the posttreatment surveillance period must be consid-
ered in the management of recurrent anterior cranial
base malignancies.
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Fig. 7. Histopathologic features of adenocarcinoma in patient 2,
displaying high-grade carcinoma with extensive gland formation
(A). H&E, original magnification 15. In contrast with Figure 5,
chromogranin staining of this tumor shows rare foci of uptake (B)
and pan-cytokeratin immunostaining is strongly positive (C), signi-
fying a change in tumor phenotype.
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